J. Masters

发表

Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin

C. O'Neill, B. Koberle, J. Masters, 1999, British Journal of Cancer.

Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio.

C. Chresta, J. Hickman, J. Masters, 1996, Cancer research.

Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines

R. Day, R. Wood, J. Masters, 2004, International journal of cancer.

Elevation of XPA protein level in testis tumor cells without increasing resistance to cisplatin or UV radiation

R. Wood, J. Masters, B. Köberle, 2008, Molecular carcinogenesis.

Regulation of DNA repair gene expression in human cancer cell lines

J. Masters, J. Hartley, C. McGurk, 2006, Journal of cellular biochemistry.

XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair.

O. G. Wong, J. Masters, C. McGurk, 2006, Biochemical pharmacology.

Human bladder cancer in vitro drug sensitivities: range and stability in long-term culture.

J. Masters, P. Hepburn, 1986, British Journal of Cancer.

Differential sensitivities of human testicular and bladder tumor cell lines to chemotherapeutic drugs.

J. Masters, M. C. Walker, C. Parris, 1987, Journal of the National Cancer Institute.

Differential sensitivities to gamma radiation of human bladder and testicular tumour cell lines.

M. Green, J. Masters, A. Lehmann, 1988, International journal of radiation biology and related studies in physics, chemistry, and medicine.

Hypersensitivity of human testis‐tumour cell lines to chemotherapeutic drugs

J. Masters, E. Osborne, C. Parris, 1993, International journal of cancer.

Complementation analysis of testis tumor cells.

J. Masters, X. Wang, M. Hafezparast, 1997, Cancer genetics and cytogenetics.

Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours

R. Wood, J. Masters, J. Hartley, 1999, Current Biology.

HeLa cells 50 years on: the good, the bad and the ugly

J. Masters, 2002, Nature Reviews Cancer.

False cell lines

J. Masters, 2002, International journal of cancer.

Changing medium and passaging cell lines

J. Masters, G. Stacey, 2007, Nature Protocols.

Detection of Mycoplasma in cell cultures

J. Masters, G. Stacey, L. Young, 2010, Nature Protocols.

Guidelines for the use of cell lines in biomedical research

R. Lovell-Badge, J. Downward, P. Thraves, 2014, British Journal of Cancer.

How diagnosis with microarrays can help cancer patients

John R. W. Masters, Sunil R. Lakhani, S. Lakhani, 2000, Nature.

Wnt signalling in prostate cancer stem-like cells

J. Masters, R. Davda, C. Thrasivoulou, 2015 .

The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.

H. Klocker, H. Patel, M. Williamson, 2004, Journal of experimental therapeutics & oncology.

Sensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapy.

J. Masters, R. Knüchel, R. Knuchel, 1989, Cancer research.

pSV3neo transfection and radiosensitivity of human cancer cell lines.

M. Green, J. Masters, C. Parris, 1990, Cancer letters.

Exceptional sensitivity of testicular germ cell tumour cell lines to the new anti-cancer agent, temozolomide.

J. Masters, M. Pera, B. Köberle, 1995, British Journal of Cancer.

The biological and clinical significance of HCG-containing cells in seminoma.

W. Gregory, J. Masters, D. Butcher, 1985, British Journal of Cancer.

Intravesical chemotherapy: Studies on the relationship between ph and cytotoxicity

E. Groos, J. Masters, L. Walker, 1986, Cancer.

The immortalized UROtsa cell line as a potential cell culture model of human urothelium.

S. Garrett, J. Masters, D. Sens, 2001, Environmental health perspectives.

Continuous Cell Lines Derived from Human Tumours as In Vitro Models for Cancer Chemotherapy: A Review

J. Masters, 1984 .

Cell-line authentication: End the scandal of false cell lines

J. Masters, 2012, Nature.

Development and characterization of cisplatin-resistant human testicular and bladder tumour cell lines.

R. Knuechel, S. Povey, J. Masters, 1990, European journal of cancer.

The differential induction of collateral resistance to 62.5 MeV (p-->Be+) neutrons and 4 MeV photons by exposure to cis-platinum.

H. Warenius, J. Masters, J. Peacock, 1993, International journal of radiation oncology, biology, physics.

Tumour markers for managing men who present with metastatic prostate cancer and serum prostate‐specific antigen levels of <10 ng/mL

A. Freeman, J. Masters, H. Payne, 2005, BJU international.

Differential expression of collateral sensitivity or resistance to cisplatin in human bladder carcinoma cell lines pre‐exposed in vitro to either X‐irradiation or cisplatin

B. Hill, J. Masters, M. C. Walker, 1987, International journal of cancer.

Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines.

S. Povey, B. Hill, J. Masters, 1986, Cancer research.

Cancer stem cells

I. Bisson, J. Masters, C. Foley, 2003, BJU international.

The comparative values of bone marrow aspirate and trephine for obtaining bone scan-targeted metastases from hormone-refractory prostate cancer

J. Masters, H. Payne, P. Ell, 2002, Prostate Cancer and Prostatic Diseases.

Genetic basis of drug sensitivity in human testis tumour cells

J. Masters, Xianghong Wang, M. Hafezparast, 1996, International journal of cancer.

Biochemical basis of resistance to chemotherapy.

J. Masters, 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Relative cytotoxicities of Adriamycin and epirubicin in combination with lonidamine against human bladder cancer cell lines

G. Zupi, M. Coptcoat, J. Masters, 2004, Urological Research.

DNA repair in cisplatin-sensitive and resistant human cell lines measured in specific genes by quantitative polymerase chain reaction.

J. Masters, B. Köberle, J. Hartley, 1996, Biochemical pharmacology.

Intravesical chemotherapy: Combination with tween 80 increases cytotoxicity in vitro

J. Masters, P. Riddle, M. C. Walker, 2004, Urological Research.

Amplification of the androgen receptor gene in bone metastases from hormone‐refractory prostate cancer

J. Bartlett, J. Masters, J. Edwards, 2002, The Journal of pathology.

PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion

J. Masters, M. Parsons, A. Whale, 2010, Journal of Cell Science.

Interferon-γ Reduces Cell Surface Expression of Annexin 2 and Suppresses the Invasive Capacity of Prostate Cancer Cells*

J. Masters, S. Moss, S. Naaby-Hansen, 2008, Journal of Biological Chemistry.

Human Cell Culture

B. Palsson, J. Masters, 1999, Human Cell Culture.

Factors influencing the sensitivity of two human bladder carcinoma cell lines to cis-diamminedichloroplatinum(II).

C. Mcauliffe, B. Hill, J. Masters, 1987, Chemico-biological interactions.

Animal cell culture

J. Masters, 2000 .

Differential Expression of CD44 During Human Prostate Epithelial Cell Differentiation

A. Freeman, J. Masters, M. O'hare, 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Comparison of marker protein expression in benign prostatic hyperplasia in vivo and in vitro

J. Masters, M. O'hare, J. Masters, 2000, BJU international.

Epithelial-mesenchymal interaction during lung development: the effect of mesenchymal mass.

J. Masters, 1976, Developmental biology.

Meeting abstractStearic acid and carcinogenesis

N. Habib, J. Masters, B. Fermor, 1987 .

Plexin-B1 signalling promotes androgen receptor translocation to the nucleus

M. Williamson, J. Masters, P. D. Winter, 2016, Oncogene.

ThioTEPA pharmacokinetics during intravesical chemotherapy: the influence of dose and volume of instillate on systemic uptake and dose rate to the tumour

M. Bibby, P. Loadman, J. Masters, 1996, Cancer Chemotherapy and Pharmacology.

Animal cell culture : a practical approach

J. Masters, 2000 .

Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines.

B. Hill, J. Masters, M. C. Walker, 1988, Cancer research.

Heat shock protein expression in testis and bladder cancer cell lines exhibiting differential sensitivity to heat.

J. Hickman, J. Masters, E. Richards, 1995, British Journal of Cancer.

Inherent sensitivity and induced resistance to chemotherapeutic drugs and irradiation in human cancer cell lines: relationship to mutation frequencies.

J. Masters, M. C. Walker, C. Parris, 1990, Cancer research.

Function of mutant and wild-type plexinB1 in prostate cancer cells

M. Williamson, J. Masters, A. Damola, 2013, The Prostate.

Can p53 staining be used to identify patients with aggressive superficial bladder cancer?

M. Parmar, A. Crook, K. Grigor, 2003, Journal of Pathology.

False cell lines: The problem and a solution

J. Masters, 2002, Cytotechnology.

Immortalisation of human urothelial cells

J. Masters, I. Leigh, C. Sexton, 2004, Urological Research.

Culture and characterisation of human urothelium in vivo and in vitro

J. Masters, I. Leigh, P. Duffy, 2004, Urological Research.

Prognostic markers in clinically localised prostate cancer.

M. C. Parkinson, J. Masters, R. Kirby, 1999, International journal of oncology.

Clinical features of patients who present with metastatic prostate carcinoma and serum prostate‐specific antigen (PSA) levels < 10 ng/mL

A. Freeman, J. Masters, H. Payne, 2003, Cancer.

Human Adult Stem Cells

B. Palsson, J. Masters, 2009 .

Binding activities of cis‐platin‐damage‐recognition proteins in human tumour cell lines

K. McLaughlin, R. Brown, J. Masters, 1993, International journal of cancer.

Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines.

A. Harris, C. Chresta, J. Masters, 1991, Cancer research.

Response to epirubicin in patients with superficial bladder cancer and expression of the topoisomerase II α and β genes

M. Coptcoat, I. Hickson, J. Masters, 1996 .

Response to epirubicin in patients with superficial bladder cancer and expression of the topoisomerase II alpha and beta genes.

M. Coptcoat, J. Masters, R. Popert, 1996, International journal of cancer.

In vitro responses of human prostate tumour cell lines to a range of antitumour agents

B. Hill, J. Masters, R. Whelan, 1983, International journal of cancer.

A conditionally immortalized cell line model for the study of human prostatic epithelial cell differentiation.

J. Masters, A. Mackay, M. O'hare, 2007, Differentiation; research in biological diversity.

Intracellular Calcium Mobilization in Response to Ion Channel Regulators via a Calcium-Induced Calcium Release Mechanism

J. Ashmore, J. Masters, C. Thrasivoulou, 2017, The Journal of Pharmacology and Experimental Therapeutics.

Human Cancer in Primary Culture, A Handbook

John R. W. Masters, J. Masters, 1991, Developments in Oncology.

Cancer cell lines

Bernhard O. Palsson, John R. W. Masters, B. Palsson, 1999 .

Check your cultures! A list of cross‐contaminated or misidentified cell lines

Amanda Capes-Davis, Arihiro Kohara, Roderick A F MacLeod, 2010, International journal of cancer.

Quantitative organ culture: an approach to prediction of tumour response.

J. Masters, E. O'donoghue, A. Krishnaswamy, 1980, The British journal of cancer. Supplement.

Cryopreservation and banking of mammalian cell lines

J. Masters, G. Stacey, 2008, Nature Protocols.

Culture of Human Urothelium

J. Southgate, J. Masters, L. Trejdosiewicz, 2002 .

Serum and tissue tumour markers in seminomas.

J. Masters, R. Oliver, D. Butcher, 1985, British journal of urology.

Thebiological andclinical significance ofHCG-containing cells inseminoma

W. Gregory, J. Masters, D. Butcher, 1985 .

Comparison of the zones of the human prostate with the seminal vesicle: Morphology, immunohistochemistry, and cell kinetics

A. Freeman, J. Masters, M. Feneley, 2005, The Prostate.

Primary cultures of renal proximal tubule cells derived from individuals with primary hyperoxaluria

J. Masters, S. Hulton, G. Rumsby, 2007, Urological Research.

Monoclonal antibodies to human urothelial cell lines and hybrids: production and characterization.

J. Southgate, J. Masters, P. Hepburn, 1985, The Journal of urology.

Immunocytochemical localisation of prostate-specific antigen: specificity and application to clinical practice.

J. Masters, D. Butcher, M. Parkinson, 1985, British journal of urology.

The effect of retinoic acid on chemosensitivity of PA‐1 human teratocarcinoma cells and its modulation by an activated N‐ras oncogene

R. Knuechel, M. Tainsky, J. Masters, 1992, International journal of cancer.

Intravesical chemotherapy with epirubicin: a dose response study.

M. Coptcoat, J. Masters, R. Popert, 1999, The Journal of urology.

O6-alkylguanine-DNA-alkyltransferase activity and nitrosourea sensitivity in human cancer cell lines.

G. Margison, J. Masters, M. C. Walker, 1992, British Journal of Cancer.

Human cancer cell lines: fact and fantasy

John R. W. Masters, J. Masters, 2000, Nature Reviews Molecular Cell Biology.

HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer

Sebastian M. Armasu, K. D. Sørensen, T. Ørntoft, 2016, Oncotarget.

HNF 1 B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer

T. Ørntoft, I. Mills, B. Fridley, 2016 .

A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF.

J. Masters, C. Wells, K. Shea, 2008, Cellular signalling.

Plexin-B1 mutation drives prostate cancer metastasis

M. Williamson, A. Clarke, J. Masters, 2020, bioRxiv.

Short tandem repeat profiling provides an international reference standard for human cell lines

J A Thomson, M. Harrison, J. Masters, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Allelic imbalance and biochemical outcome after radical prostatectomy

M. Williamson, J. Masters, R. Kirby, 2006, Prostate Cancer and Prostatic Diseases.

Effect of cancer-associated mutations in the PlexinB1 gene

O. G. Wong, M. Williamson, J. Masters, 2012, Molecular Cancer.

Plexin-B1 mutations in prostate cancer

H. Klocker, A. Freeman, O. G. Wong, 2007, Proceedings of the National Academy of Sciences.

Human Cell Culture

B. Palsson, H. Drexler, H. Findley, 2002, Human Cell Culture.

Targets of Wnt/ß-Catenin Transcription in Penile Carcinoma

J. Masters, R. Henrique, M. Arya, 2015, PloS one.

DNA Repair capacity and cisplatin sensitivity of human testis tumour cells

J. Masters, L. Kèlland, J. Hartley, 1997, International journal of cancer.

Bladder cancer cell line cross-contamination: identification using a locus-specific minisatellite probe.

S. Povey, J. Masters, L. M. Franks, 1988, British Journal of Cancer.

Match criteria for human cell line authentication: Where do we draw the line?

James A. Thomson, Yukio Nakamura, Amanda Capes-Davis, 2013, International journal of cancer.

Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissues

Amanda Capes-Davis, Douglas R. Storts, Yvonne A. Reid, 2010, In Vitro Cellular & Developmental Biology - Animal.

CD49f Is an Efficient Marker of Monolayer- and Spheroid Colony-Forming Cells of the Benign and Malignant Human Prostate

P. Dasgupta, A. Freeman, J. Masters, 2012, PloS one.

Epithelial Cell Differentiation Pathways in the Human Prostate: Identification of Intermediate Phenotypes by Keratin Expression

F. Watt, J. Masters, M. O'hare, 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Proliferative Heterogeneity in the Human Prostate: Evidence for Epithelial Stem Cells

F. Watt, J. Masters, M. O'hare, 2000, Laboratory Investigation.

Intravesical chemotherapy: studies on the relationship between osmolality and cytotoxicity.

E. Groos, J. Masters, 1986, The Journal of urology.

Sensitivity of testis tumour cells to chemotherapeutic drugs: role of detoxifying pathways.

A. Hall, H. Lohrer, J. Masters, 1996, European journal of cancer.

Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi‐arm, multistage randomized controlled trial

John Dwyer, M. Sydes, D. Dearnaley, 2009, BJU international.

A Novel Role for Wnt/Ca2+ Signaling in Actin Cytoskeleton Remodeling and Cell Motility in Prostate Cancer

Christopher Thrasivoulou, John R. W. Masters, Alex Freeman, 2010, PloS one.

Cell line cross-contamination: WSU-CLL is a known derivative of REH and is unsuitable as a model for chronic lymphocytic leukaemia.

Amanda Capes-Davis, Tanya Barrett, Lyn Healy, 2014, Leukemia research.

Clinical applications of expression profiling and proteomics in prostate cancer.

J. Masters, 2007, Anticancer research.

Steroid receptor assays as prognostic aids in the treatment of breast cancer

J. Masters, R. Rubens, J. Hayward, 1980 .

Intravesical chemotherapy: In vitro studies on the relationship between dose and cytotoxicity

J. Masters, P. Hepburn, M. C. Walker, 2004, Urological Research.

Clonogenicity: Holoclones and Meroclones Contain Stem Cells

J. Masters, C. Beaver, A. Ahmed, 2014, PloS one.

STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer--a multi-arm multi-stage randomised controlled trial.

M. Parmar, M. Sydes, D. Dearnaley, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

Elastosis and response to endocrine therapy in human breast cancer.

J. Masters, R. Rubens, R. Millis, 1979, British Journal of Cancer.

21st Century molecular biology in urology

J. Masters, S. Naaby-Hansen, M. Williamson, 2001, BJU international.

Curing metastatic cancer: lessons from testicular germ-cell tumours

J. Masters, B. Köberle, 2003, Nature Reviews Cancer.

Quantitative Expression and Co-Localization of Wnt Signalling Related Proteins in Feline Squamous Cell Carcinoma

I. McGonnell, J. Masters, J. McKay, 2016, PloS one.

KW-2149 (7-N-[2-[gamma-L-glutamylamino]ethyldithioethyl] mitomycin C): DNA interactions and drug uptake following serum activation.

J. Masters, J. Hartley, R. Knox, 1998, Biochemical pharmacology.

Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors.

A. Freeman, M. Williamson, J. Masters, 2009, Asian journal of andrology.

Histological grade, elastosis, DNA ploidy and the response to chemotherapy of breast cancer.

R. Camplejohn, J. Masters, R. Rubens, 1987, British Journal of Cancer.

Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons

M. Zvelebil, C. Wood, J. Masters, 2004, Oncogene.

The Makari skin test and immunocompetence in bladder cancer

J. Masters, K. Munson, D. Tee, 2004, Urological Research.

Proteomics in the analysis of prostate cancer.

J. Masters, K. Nagano, R. Cramer, 2003, Methods in molecular medicine.

Allelic imbalance at 13q14.2∼q14.3 in localized prostate cancer is associated with early biochemical relapse

A. Freeman, J. Masters, R. Kirby, 2007 .

Quantitative Analysis of BTF3, HINT1, NDRG1 and ODC1 Protein Over-Expression in Human Prostate Cancer Tissue

A. Freeman, J. Masters, M. Feneley, 2013, PloS one.

Combined affinity labelling and mass spectrometry analysis of differential cell surface protein expression in normal and prostate cancer cells

J. Masters, R. Cramer, S. Naaby-Hansen, 2005, Oncogene.

Chemosensitivity in Human Tumor Cell Lines Relationship between Topoisomerase II Level and Updated Version

A. Harris, I. Hickson, Christine, 2006 .

Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro

J. Masters, J. Masters, M. Wyllie, 1994, The Journal of Steroid Biochemistry and Molecular Biology.

Mechanism of differential sensitivity to cisplatin in nasopharyngeal carcinoma cells.

S. Tsao, J. Masters, X. Wang, 2001, Anticancer research.

Fatty acid composition of normal and malignant cells and cytotoxicity of stearic, oleic and sterculic acids in vitro.

N. Habib, J. Masters, B. Fermor, 1992, European journal of cancer.

Rho family GTPases are activated during HGF-stimulated prostate cancer-cell scattering.

G. E. Jones, J. Masters, C. Wells, 2005, Cell motility and the cytoskeleton.

Superficial bladder cancer: the response of a marker tumour to a single intravesical instillation of epirubicin.

M. Parmar, M. Coptcoat, J. Masters, 1994, British journal of urology.

Biochemical relapse following radical prostatectomy and miR‐200a levels in prostate cancer

A. Freeman, N. Barron, M. Clynes, 2012, The Prostate.

Allelic imbalance at 13q14.2 approximately q14.3 in localized prostate cancer is associated with early biochemical relapse.

A. Freeman, J. Masters, R. Kirby, 2007, Cancer genetics and cytogenetics.

In vitro assessment of a collagen sponge for engineering urothelial grafts.

R. Brown, J. Masters, D. Herbage, 1998, British journal of urology.

Human Cell Culture

B. Palsson, C. Boshoff, A. Virmani, 2002, Human Cell Culture.

Plexin-B1 mutations in prostate cancer.

H. Klocker, A. Freeman, O. G. Wong, 2008, Proceedings of the National Academy of Sciences of the United States of America.

Correction: Quantitative Analysis of BTF3, HINT1, NDRG1 and ODC1 Protein Over-Expression in Human Prostate Cancer Tissue

A. Freeman, J. Masters, M. Feneley, 2014, PLoS ONE.

Prostate cancer proteomics.

J. Masters, John R Masters, 2011, Omics : a journal of integrative biology.

The photodynamic effect of a pulsed dye laser on human bladder carcinoma cells in vitro

J. Masters, A. Macrobert, A. J. Pope, 2004, Urological Research.

False cell lines.

J. Masters, 2002, Carcinogenesis.

Screening of new anticancer agents in vitro using panels of human cell lines derived from non-seminomatous germ cell tumours and transitional cell carcinomas of the bladder.

R. Shoemaker, J. Masters, W. Jenkins, 1992, European journal of cancer.

The biological characteristics of continuous cell lines derived from human bladder

J. Masters, P. Hepburn, 1983 .

A role for class 3 semaphorins in prostate cancer

H. Klocker, A. Freeman, M. Williamson, 2011, The Prostate.

Oestrogen receptors, cellularity, elastosis and menstrual status in human breast cancer.

A. Forrest, J. Masters, J. Masters, 1978, European Journal of Cancer.

Ultra high field NMR spectroscopic studies on human seminal fluid, seminal vesicle and prostatic secretions.

M. Spraul, J. Lindon, J. Nicholson, 1994, Journal of pharmaceutical and biomedical analysis.

Title Effect of cancer-associated mutations in the PlexinB 1 gene

O. G. Wong, M. Williamson, J. Masters, 2012 .

Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer

Q Wang, M. Hubank, A. Freeman, 2007, Oncogene.

Cell Line Authentication and Characterisation

J. Masters, Y. Reid, 2014 .

Thio TEPA pharmacokinetics during intravesical chemotherapy and the influence of Tween 80

A. Mundy, M. Bibby, P. Loadman, 2004, Cancer Chemotherapy and Pharmacology.

Prostate cancer

J. Masters, 2003, British Journal of Cancer.

Response to endocrine therapy and breast cancer differentiation

J. Masters, R. Rubens, R. Millis, 2005, Breast Cancer Research and Treatment.

Check your cultures! A list of cross‐contaminated or misidentified cell lines

A. Kohara, H. Drexler, R. Reddel, 2010, International journal of cancer.

Match criteria for human cell line authentication: Where do we draw the line?

R. Nardone, A. Kohara, H. Drexler, 2013, International journal of cancer.

Re: false cell lines.

J. Masters, 2002, Experimental cell research.

Cell-line authentication: End the scandal of false cell lines

A. McBratney, R. Lal, J. Masters, 2012, Nature.

STEM CELLS IN REGENERATIVE UROLOGY OF THE BLADDER

P. Dasgupta, J. Masters, R. Popert, 2009, BJU international.